Soybean oil increases SERCA2a expression and left ventricular contractility in rats without change in arterial blood pressure
© Ribeiro et al; licensee BioMed Central Ltd. 2010
Received: 25 March 2010
Accepted: 26 May 2010
Published: 26 May 2010
Our aim was to evaluate the effects of soybean oil treatment for 15 days on arterial and ventricular pressure, myocardial mechanics and proteins involved in calcium handling.
Wistar rats were divided in two groups receiving 100 μL of soybean oil (SB) or saline (CT) i.m. for 15 days. Ventricular performance was analyzed in male 12-weeks old Wistar rats by measuring left ventricle diastolic and systolic pressure in isolated perfused hearts according to the Langendorff technique. Protein expression was measured by Western blot analysis.
Systolic and diastolic arterial pressures did not differ between CT and SB rats. However, heart rate was reduced in the SB group. In the perfused hearts, left ventricular isovolumetric systolic pressure was higher in the SB hearts. The inotropic response to extracellular Ca2+ and isoproterenol was higher in the soybean-treated animals than in the control group. Myosin ATPase and Na+-K+ATPase activities, the expression of sarcoplasmic reticulum calcium pump (SERCA2a) and sodium calcium exchanger (NCX) were increased in the SB group. Although the phosfolamban (PLB) expression did not change, its phosphorylation at Ser16 was reduced while the SERCA2a/PLB ratio was increased.
In summary, soybean treatment for 15 days in rats increases the left ventricular performance without affecting arterial blood pressure. These changes might be associated with an increase in the myosin ATPase activity and SERCA2a expression.
Soybean oil and other oils rich in polyunsaturated fatty acids (PUFAs) are thought to be beneficial to cardiovascular health [1–3]. Their effects can be attributed to the presence of alpha-linolenic acid, an essential n-3 fatty acid found in vegetable cooking oils such as soybean and canola oils. In fact, a previous report suggested that both dietary and adipose levels of alpha-linolenic acid were associated with a large reduction in the risk of nonfatal acute myocardial infarction [1–3] and low consumption of alpha-linolenic acid has been correlated with an increase of coronary heart disease and sudden death of cardiac origin .
Alpha-linolenic acid can not be produced in the body and must be taken in by food. In both animals and humans, alpha-linolenic acid is desaturated and elongated into eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid. It is also incorporated into plasma and tissue lipids, and its conversion is affected by the levels of linoleic acid.
McLennan  reported that when the major dietary fat was sunflower seed oil (77% linoleic acid) there was a 70% reduction in fatal ventricular fibrillation when coronary arteries were ligated compared with diets high in saturated or monounsaturated fats. Soybean oil contains over 50% linoleic acid. Therefore, it could contribute to the cardiac beneficial effects of soybean oil.
Pepe and McLennan  showed that fish oil improves postischemic recovery of cardiac contractile function. In their study, EPA and DHA were attributed as the primary causes for the efficacy of fish oil. Other sources of alpha-linoleic acid include canola, soybeans, and some fish including salmon. However, the mechanisms by which soybean oil exerts its cardiac protective effects have not yet been elucidated. Therefore, the goal of the present study was to investigate the effects of 15 days of soybean oil treatment in young healthy male rats on arterial and left ventricular pressure, left ventricular function of isolated perfused hearts, the Na+-K+ATPase (NKA), myosin ATPase activities and the expression of calcium handling proteins.
Material and methods
Animals and soybean oil treatment
Male 12-week old Wistar rats were used. Rats were housed at constant room temperature, humidity and light cycles, (12 h light/dark), with free access to tap water and were fed standard rat chow ad libitum. Care and use of laboratory animals and all experiments were in compliance with the guidelines for biomedical research, as stated by the Brazilian Societies of Experimental Biology and approved by the local ethics committee (EMESCAM -003/2007).
Rats were divided in two groups: soybean oil treatment (SB) and control (CT). The treated group received a daily dose of 0.1 mL (i.m.) of soybean oil for 15 days and the control group received a similar volume of 0.9% NaCl.
Arterial blood pressure and left ventricular pressure measurements
At the end of treatment, rats were anesthetized with urethane (1.2 g/kg) and a polyethylene catheter (PE50) filled with heparinized saline (50 U/mL) was introduced into the carotid artery to measure the arterial systolic blood pressure (SBP) and diastolic blood pressure (DBP). The carotid artery catheter was introduced into the left ventricle to measure the systolic pressure (LVSP) and its positive and negative first derivatives (dP/dt max LV and dP/dt min LV, respectively), as well as the left ventricular end diastolic pressure (LVEDP). Following this procedure, the catheter was withdrawn from the LV and the arterial pressure was measured again to determine if damage to the aortic valve had occurred. The animal was discarded if a decrease in the diastolic blood pressure was observed.
Isolated heart perfusion
After hemodynamic measurements, rats were treated with heparin (500 UI, i.p.) and after 10 minutes the heart was excised and mounted in an isolated organ chamber. The heart was then perfused according to the Langendorff technique at constant flow (10 mL/min) with Krebs bicarbonate buffered solution containing (in mM): 120 NaCl, 5.4 KCl, 1.25 CaCl2, 2.5 MgSO4, 1.2 Na2SO4, 2.0 NaH2PO4, 20 NaHCO3 and 11 glucose. This solution was continuously bubbled with 95% O2 and 5% CO2 (pH = 7.4) at 31°C. After mounting, the left atrium was opened and a soft distensible latex balloon mounted at the tip of a rigid plastic tube was inserted into the left ventricular cavity through the atrioventricular valve. The balloon was connected, via a Y piece, to a pressure transducer (TSD104A) and a syringe so that the diastolic pressure (DP) of the left ventricle could be adjusted to predetermined values by injecting water into the balloon. The developed left ventricular isovolumic systolic pressure (LVISP) was recorded using the pressure transducer (TSD104A) connected to the Biopac System (MP100; CA). The hearts were driven with isolated suprathreshold rectangular pulses (5 ms duration) at a baseline constant rate of 200 bpm using a pair of Ag/AgCl electrodes attached to the upper region of the right ventricle. All measurements began 1 h after mounting to allow the beating preparation to adapt to the in vitro conditions. The coronary perfusion pressure (CPP) was continuously recorded by connecting a pressure transducer (TSD104A) to the aortic pressure tube. Since coronary flow was kept constant (10 mL/min), changes of the CPP were dependent on changes of coronary resistance. Ventricular function curves were obtained by measuring the LVISP that developed while DP was increased from 0 to 30 mm Hg in 5 mm Hg steps.
To analyze the force-frequency relationship, the frequency was gradually increased from 200 to 350 bpm in 50 bpm steps. To analyze the inotropic response to Ca2+, the diastolic pressure was set at 10 mmHg and the steady-state LVISP was measured by increasing extracellular Ca2+ concentrations (0.62; 1.25; 1.87; 2.5; and 3.12 mM). Finally, a single dose of isoproterenol (100 μL, 10-5 M) was administered to evaluate the β-adrenoceptor response.
Cardiac myosin ATPase activity
Preparation of tissue
Myosin was prepared from minced and homogenized left ventricles extracted briefly with KCl-phosphate buffer (0.3 M KCl and 0.2 M phosphate buffer) pH = 6.5. After precipitating myosin using a 15-fold dilution with water, the muscle residue was separated by filtration using cheesecloth. This procedure precipitates fragments of cells, including the membranes. The myosin-containing filtrate was centrifuged at 10,000 × g for 40 min. The precipitate was re-dissolved in phosphate buffer and 0.6 M KCl to elute the myosin under high ionic strength, and 1 mL of water was added for each gram of tissue to generate a new precipitate. The material was again centrifuged at 10,000 × g for 40 min and the muscle residue was separated by filtration. The material was re-dissolved again in 14 mL of water per gram of tissue, centrifuged, and filtered as before. The precipitate was dissolved in 50 mM N-(2-hydroxuethylpiperazine-N'-[2-ethanesulfonic acid]) sodium salt (HEPES pH 7) and 0.6 M KCl plus 50% glycerol (v/v) and stored at -20°C. Stored myosin was diluted in water (1:12) and centrifuged at 10,000 × g for 40 min. The precipitate was re-suspended in 50 mM HEPES (pH 7) and 0.6 M KCl and centrifuged at 600 × g for 5 min. The supernatant was used for enzyme assays.
Assay to determine myosin ATPase activity
Myosin ATPase activity was determined by measuring inorganic phosphate (Pi) liberation from 1 mM ATP in the presence of 50 mM HEPES (pH 7), 0.6 M KCl, 5 mM CaCl2, or 10 mM ethylene glycol-bis (β-amino ethyl ether)-N,N,N',N'-tetra acetic acid (EGTA) in a final volume of 200 μL. ATP was added to the reaction mixture and pre-incubated for 5 minutes at 30°C. The reaction was initiated by adding the enzyme fraction (3-5 μg protein) to the reaction mixture. Samples were assayed in duplicate or triplicate and corrected for non-enzymatic hydrolysis by using controls assayed in the same conditions, except that the protein sample was added after interruption of the reaction using 200 μL of 10% trichloroacetic acid. The reaction was initiated by the addition of the protein sample to avoid the inactivation at 30°C caused by the lack of substrate. Pi concentration was determined by a previously described method . The specific activity was reported as nmol Pi released per min per mg of protein. Protein concentration was measured according to the Bradford method  using bovine serum albumin as the standard.
Na+-K+ ATPase activity
The enzymatic material was extracted as previously described . Briefly, ventricular tissue was homogenized in a solution containing 20 mM Tris-HCl and 1 mM EDTA, pH 7.5. The homogenized tissue was centrifuged at 10,000 g for 20 minutes and precipitate was discarded. The supernatant was centrifuged at 10,500 g for one hour. The precipitate was resuspended in 20 mM Tris-HCl and 1 mM EDTA, pH 7.5 in a final volume of 400 μL.
Na+-K+ ATPase activity was assayed by measuring Pi liberation from 3 mM ATP in the presence of 125 mM NaCl, 3 mM MgCl2, 20 mM KCl, and 50 mM Tris-HCl (pH 7.5). The enzyme was preincubated for 5 minutes at 37°C and the reaction was initiated by adding ATP. Incubation times and protein concentration were chosen to ensure the linearity of the reaction. The reaction was quenched by the addition of 200 μL of 10% trichloroacetic acid. Controls with addition of the enzyme preparation after addition of trichloroacetic acid were used to correct for nonenzymatic hydrolysis of the substrate. All samples were examined in duplicate. The specific activity was reported as nmol Pi released per min per mg of protein unless otherwise stated. The specific activity of the enzyme was determined in the presence and absence of 5 mM ouabain.
Western blot analysis
Proteins from homogenized hearts (50 μg for phosfolamban (PLB) and 100 μg for the other proteins) were separated by SDS-PAGE. Proteins were transferred to nitrocellulose membranes and incubated with mouse monoclonal antibodies for sarcoplasmic reticulum calcium pump (SERCA2a) (1:500, Affinity BioReagents, CO, USA), Na+Ca2+ exchange (NCX) (1:200, Abcam Cambridge, MA, USA), PLB (1 μg/ml, Affinity BioReagents, CO, USA), α1 of the Na+-K+ ATPase (NKA) (1:1000, Upstate Massachusetts, USA), α2 of the NKA (1:1000, Upstate Massachusetts, USA) and rabbit polyclonal antibodies for PLB phospho-Ser16 (1:5000, Badrilla, Leeds, UK). After washing, membranes were incubated with anti-mouse or anti-rabbit (1:5000, StressGen, Victoria, Canada) immunoglobulin antibody conjugated to horseradish peroxidase. After washing, immunocomplexes were detected using an enhanced horseradish peroxidase/luminal chemiluminescence system (ECL Plus, Amersham International, Little Chalfont, UK) and film (Hyperfilm ECL International). Signals on the immunoblot were quantified using the National Institutes of Health Image V1.56 computer program. As a loading control, the same membrane was used to determine GAPDH expression using a mouse monoclonal antibody (1:5000, Abcam Cambridge, MA, USA).
Drugs and chemicals
Salts and reagents used, when not otherwise indicated, were purchased from Sigma and Merck (Darmstadt, Germany).
The results are presented as mean ± SEM, with "N" indicating the number of observations. Values were analyzed using the t-test or ANOVA (one-and two-way). When ANOVA revealed a significant difference, the Tukey test was applied. p < 0.05 was considered significant.
At the end of the treatment, the body weight of animals treated with soybean oil was similar to controls (SB: 346 ± 5.5 vs. CT: 347 ± 7.2 g). Soybean oil treatment did not cause significant alterations in the left ventricle to body weight ratio compared to controls (SB: 1.91 ± 0.06 vs. CT: 1.92 ± 0.2 mg/g), suggesting that ventricular hypertrophy did not occur.
Changes in systolic (SBP) and diastolic blood pressure (DBP), heart rate (HR), left (LVSP) ventricle systolic pressure, left ventricle diastolic pressure (LVEDP), and the positive (dP/dt max) and negative first time derivatives (dP/dt min) from control (CT) and soybean oil-treated rats (SB).
CT (n = 11)
SB (n = 6)
SBP (mm Hg)
103 ± 4.10
94 ± 4.11
DBP (mm Hg)
60 ± 4.06
56 ± 3.63
315 ± 13
270 ± 12*
LVSP (mm Hg)
113 ± 4.01
118 ± 5.35
LVEDP (mm Hg)
4.38 ± 0.53
6.0 ± 0.44
dP/dt max LV (mm Hg/sec)
5045 ± 289
4401 ± 451
dP/dt min LV (mm Hg/sec)
-5436 ± 225
-5112 ± 314
To investigate if soybean oil treatment affected the action of inotropic interventions, heart rate and extracellular Ca2+ (0.62-3.12 mM) increment were examined. As expected, in the rat myocardium the increase of the rate of stimulation reduced LVISP in both groups (Figure 1B). However, LVISP was higher in the soybean oil group for all rate changes when compared to the control group.
The extracellular Ca2+ increment increased the LVISP in both groups, however in the SB treated rats this increment was enhanced when compared to the control group (Figure 1C).
In this study, we demonstrated that treatment with soybean oil for 15 days is associated with an increased inotropic function of the left ventricle in an isolated perfused heart. This treatment did not cause cardiac hypertrophy but increased myosin, Na+-K+ ATPase activities, SERCA2a and NCX expression. Although PLB expression levels did not change, its phosphorylation was reduced. Also, in the present study, the soybean oil treatment did not affect blood pressure, but decreased the heart rate. Although SB-treated rats presented an increased inotropic response in isolated heart preparations, they did not exhibit changes in arterial or ventricular pressures. These results suggested that, in vivo, other mechanisms blunt the positive inotropism induced by soybean oil treatment. The reduction in heart rate suggests that reflex mechanisms might be involved.
The intrinsic, Frank-Starling mechanism, and extrinsic, β-adrenergic, inotropic responses evaluated in vitro showed an increment after treatment with soybean oil suggesting better myocardial performance. These findings are interesting as they were not associated with an increase in arterial blood pressure. A putative explanation for the better ventricular performance of the isolated hearts might be the increased myosin ATPase activity, NCX and SERCA2a expression, which are related to positive inotropism and regulation and maintenance of sarcoplasmic reticulum calcium load [10–12]. These findings might explain previous in vitro results [13, 14]. The sarcoplasmic reticulum is essential to regulate cytosolic calcium during myocardial contraction and relaxation. Sarcoplasmic reticulum calcium reuptake rate is regulated by the SERCA2a capacity. SERCA2a activity is regulated by a small molecular weight protein, PLB that can be phosphorylated at the serine 16 residue via the β-adrenergic pathway and the threonine 17 residue primarily via the calcium/calmodulin kinase II . The phosphorylation status of PLB (p-PLB) has been related to the β-adrenergic signaling pathways . Phosphorylation at either site is sufficient to remove the inhibitory effect of PLB on SERCA2a  and results in increased SR-Ca2+ uptake with enhanced myocyte contractility and relaxation. Our finding that PLB phosphorylated at serine16 was significantly reduced without any affect on PLB protein expression suggests a reduction in PKA-dependent PLB phosphorylation or an increase in dephosphorylated PLB  upon soybean oil treatment. A reduction in PKA-dependent PLB phosphorylation was shown to be dependent on changes in various levels of β-adrenergic signaling . However, the present study demonstrated that even though p-PLB was reduced, SERCA2a protein expression was increased, thus resulting in a higher SERCA2a to PLB ratio. Indeed, previous report  suggests that the enrichment in docosahexaenoic acid (DHA) in cardiomyocytes phospholipids exerts positive influence on the β-adrenergic transduction mechanism, essentially through an increase of cAMP efficiency. The amount of DHA could be incorporated in cardiac membranes following fish or soybean oil diets. Therefore, we could speculate that the treatment with soybean oil could increase the amount of DHA in cardiomyocytes membranes phospholipids, which, in turn, could explain the increased β-adrenergic response in the soybean group.
The most well described disturbances in myocardial contractility are intimately dependent on the active transport of ions, namely Ca2+ and Na+, which are regulated by SERCA2a and the Na+-K+ ATPase. The Na+-K+ ATPase is a heteromeric protein consisting of α and βα subunits. While the α subunit contains the amino acids involved in catalytic function, ion transport and cardiac glycoside binding, the function of the β subunit, although not yet fully understood, is essential for normal activity of the enzyme and is involved in transport of the functional Na+-K+ ATPase in the plasma membrane . The results of the present study demonstrate that soybean oil treatment increased expression of the α1 and α2 Na+-K+ ATPase protein subunits and its enzymatic activity. We speculate that this could be a cellular adaptation due to chronically higher intracellular Na+. This hypothesis is based on the results of a previous study in aortic smooth muscle cells . These authors suggested that Na+-induced upregulation of the Na+-K+ ATPase α isoforms could be interpreted as an attempt by the cell to increase membrane Na+ transport to remove excess Na+ and restore it to normal intracellular levels. In cardiac myocytes, since an increase in Na+ concentration is associated with an increase in the intracellular Ca2+ concentration, the latter may contribute to the positive inotropic effect of soybean oil we observed. More recently a study have demonstrated that activation of the Na+-K+ ATPase modulates cardiac L-type Ca2+ channel function, leading to elevated sarcoplasmic reticulum Ca2+ release and intracellular Ca2+ transients . These data led to a new mechanism that could explain the increased activity of the Na+-K+ ATPase associated with a positive inotropic effect of soybean oil treatment. However, to confirm our hypothesis the intracellular Na+ and Ca2+ need to be measured.
In conclusion, soybean oil treatment for 15 days in rats, although not affecting arterial pressure and LVSP, causes an increase in the left ventricular performance in the isolated heart. These changes were associated with increased SERCA2a expression and myosin ATPase activity. These findings are relevant because they help to clarify some of the cardioprotective mechanisms induced by soybean oil.
This study was supported by grants from CNPq, FAPES/FUNCITEC and CAPES.
- Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H: Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation. 2003, 107: 1586-1591. 10.1161/01.CIR.0000058165.81208.C6View ArticlePubMedGoogle Scholar
- Hu FB, Manson JE, Willett WC: Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nut. 2001, 20: 5-19.View ArticleGoogle Scholar
- Campos H, Baylin A, Willett WC: Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation. 2008, 118: 339-345. 10.1161/CIRCULATIONAHA.107.762419PubMed CentralView ArticlePubMedGoogle Scholar
- Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, Hennekens CH, Willett WC: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nut. 1999, 69: 890-897.Google Scholar
- McLennan PL: Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nut. 1993, 57: 207-212.Google Scholar
- Pepe S, McLennan PL: Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and post-ischemic recovery of contractile function. Circulation. 2002, 105: 2303-2308. 10.1161/01.CIR.0000015604.88808.74View ArticlePubMedGoogle Scholar
- Moreira CM, Oliveira EM, Bonan CD, Sarkis JJ, Vassallo DV: Effects of mercury on myosin ATPase in the ventricular myocardium of the rat. Comp Biochem Physiol C Toxicology Pharmacology. 2003, 135C (3): 269-75. 10.1016/S1532-0456(03)00110-8.View ArticleGoogle Scholar
- Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Annual Biochemistry. 1976, 72: 218-254.View ArticleGoogle Scholar
- Stefanon I, Cade JR, Fernandes AA, Ribeiro RF, Targueta GP, Mill JG, Vassallo DV: Ventricular performance and Na+-K+ ATPase activity are reduced early and late after myocardial infarction in rats. B J Med Biol Res. 2009, 43: 902-911.View ArticleGoogle Scholar
- Barany K: ATPase activity of myosin correlated with speed of muscle shortening. J of Gen Physiol. 1967, 5: 197-216. 10.1085/jgp.50.6.197.View ArticleGoogle Scholar
- del Monte F, Harding SE, Schmidt U, Matsui T, Kang ZB, Dec GW, Gwathmey JK, Rosenzweig A, Hajjar RJ: Restoration of Contractile Function in Isolated Cardiomyocytes from Failing Human Hearts by Gene Transfer of SERCA2a. Circulation. 1999, 100: 2308-2311.PubMed CentralView ArticleGoogle Scholar
- Weisser-Thomas J, Piacentino V, Gaughan JP, Margulies K, Houser SR: Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovascular Research. 2003, 57: 974-85. 10.1016/S0008-6363(02)00732-0View ArticlePubMedGoogle Scholar
- Barnes GE, Bishop VS, Horwitz LD, Kaspar RL: The maximum derivatives of left ventricular pressure and transverse internal diameter as indices of the inotropic state of the left ventricle in conscious dogs. J Physiol. 1973, 235: 571-590.PubMed CentralView ArticlePubMedGoogle Scholar
- Braunwald E: A Textbook of Cardiovascular Medicine. 1992, 419-43. WB Saunders, Philadelphia, 4,Google Scholar
- Sande JB, Sjaastad I, Hoen IB, Bokenes J, Tonnessen T, Holt E: Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc Res. 2002, 53: 382-391. 10.1016/S0008-6363(01)00489-8View ArticlePubMedGoogle Scholar
- Jackson WA, Colyer J: Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca2+-pump stimulation. Biochem J. 1996, 316: 201-207.PubMed CentralView ArticlePubMedGoogle Scholar
- MacDougall LK, Jones LR, Cohen P: Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem. 1991, 196: 725-34. 10.1111/j.1432-1033.1991.tb15871.xView ArticlePubMedGoogle Scholar
- Bristow MR, Ginsburg R, Minobe W: Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. New Eng J Med. 1982, 307: 205-211.View ArticlePubMedGoogle Scholar
- Grynberg A, Fournier A, Sergiel JP, Athias P: Effect of docosahexaenoic acid and eicosapentaenoic acid in the phospholipids of rat heart muscle cells on adrenoceptor responsiveness and mechanism. J Mol Cell Cardiol. 1995, 27: 2507-2520. 10.1006/jmcc.1995.0238View ArticlePubMedGoogle Scholar
- Schwinger RH, Bundgaard H, Müller-Ehmsen J, Kjeldsen K: The Na+, K+-ATPase in the failing human heart. Cardiovasc Res. 2003, 57: 913-920. 10.1016/S0008-6363(02)00767-8View ArticlePubMedGoogle Scholar
- Liu X, Songu-Mize E: Effect of Na+ on Na+, K+-ATPase a subunit expression and Na pump activity. Eur J Pharmacol. 1998, 351: 113-119. 10.1016/S0014-2999(98)00278-7View ArticlePubMedGoogle Scholar
- Lee DI, Klein MG, Zhu W, Xiao RP, Gerzanich V, Xu KY: Activation of (Na+-K+)-ATPase Modulates Cardiac L-Type Ca2+ Channel Function. Mol Pharmacol. 2009, 75: 774-781. 10.1124/mol.108.052597PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.